Causes and Risk Factors for Ewing Sarcoma
Ewing sarcoma is a rare and aggressive cancer that primarily affects bones or soft tissue, most often in children and young adults. Understanding the genetic changes and risk factors behind it is important for both research and patient education.
Key Takeaways
- Ewing sarcoma’s defining cause is an acquired chromosomal change — usually the EWSR1-FLI1 fusion gene — found, according to the National Cancer Institute, in roughly 85% to 90% of cases.
- Age and ethnicity are the most consistently identified risk factors: the disease mainly affects children, teens, and young adults, and in the United States it’s diagnosed several times more often in White individuals than in Black or Asian individuals.
- Most cases arise without any inherited cause, though research has begun to turn up modest genetic-susceptibility signals, including a possible link to Fanconi anemia, that set Ewing sarcoma apart from a purely random disease.
- No specific environmental exposure, diet, or lifestyle factor has been established as a cause of Ewing sarcoma.
- Genomic research continues to map the fusion gene’s effects and other tumor mutations, work aimed at eventually finding new treatment targets.
Genetic Translocations: Ewing Sarcoma Causes
Ewing sarcoma’s cause is best understood at the level of a single cell’s DNA rather than as something passed down from a parent. In most cases, a piece of one chromosome breaks off and attaches to a different chromosome, forming a new, abnormal gene where two unrelated genes used to be. This kind of error, called a chromosomal translocation, is considered the molecular signature of the disease.
Because this translocation happens after conception rather than being inherited, it’s classified as a somatic mutation — present in the tumor cells but not in the rest of the body, and not something that can be passed to future children.
The EWSR1-FLI1 Fusion Gene
The translocation joins a gene called EWSR1, located on chromosome 22, with a gene called FLI1, found on chromosome 11; that break-and-rejoin event welds the two into the EWSR1-FLI1 fusion gene. The National Cancer Institute reports that this specific pairing accounts for 85% to 90% of pediatric Ewing sarcoma cases.
The fusion produces an abnormal protein that behaves like a rogue transcription factor, a switch that turns genes on and off. Rather than following the body’s normal signals, it disrupts the activity of numerous other genes involved in cell growth and division, which is thought to be the central step that starts and sustains the tumor.
Role of Chromosomal Abnormalities
EWSR1-FLI1 is the most common pairing, but not the only one. In a smaller share of cases, the EWSR1 gene joins with a different partner from the same gene family — including ERG, ETV1, ETV4, or FEV — producing a fusion protein that works in a similar way. Occasionally, a related gene called FUS substitutes for EWSR1 entirely. Like the more common EWSR1-FLI1 pairing, these are all somatic changes rather than inherited ones, and what first triggers them in a given cell isn’t known.
Key Risk Factors for Ewing Sarcoma
Outside of the translocation itself, a handful of demographic and biological patterns have been consistently observed in who develops Ewing sarcoma. These are risk factors rather than causes — they don’t explain the disease at a molecular level, but they help identify who is more likely to be affected.
Age and Ethnicity
Ewing sarcoma is primarily a disease of childhood, adolescence, and young adulthood, with most cases diagnosed from the teenage years into the mid-20s; it is uncommon in very young children and in older adults.
Ethnicity is the other clearly established pattern. In the United States, incidence is roughly nine times higher among White individuals than Black individuals, with an intermediate rate among Asian individuals. Part of this gap may trace back to a specific variation in the EGR2 gene that is far more common in White populations and appears to amplify the effect of the EWSR1-FLI1 fusion protein — a case where a risk factor and a molecular cause appear to intersect.
Family History and Genetic Predisposition
Ewing sarcoma is usually described as sporadic, meaning it typically arises without a family history or an inherited syndrome behind it — a real difference from cancers where a single inherited gene variant confers a high lifetime risk on its own. That said, sporadic isn’t the same as entirely unrelated to genetics. The National Cancer Institute notes that children with Fanconi anemia, an inherited condition, may face an increased risk of Ewing sarcoma, and a case-control study of pediatric sarcoma patients found that inherited variants in the Fanconi-anemia-related FANCC gene turned up more often in people with Ewing sarcoma than in cancer-free comparison groups. Genome-wide studies have also flagged several regions of the genome linked to a modestly higher risk.
None of this amounts to a defined hereditary cancer syndrome of the kind linked to some other bone cancers. For most families, having a relative with Ewing sarcoma does not meaningfully raise personal risk, though a family history of Fanconi anemia or early-onset cancer is a reasonable reason to ask a doctor whether genetic counseling would help.
Environmental and Lifestyle Influences
Many adult cancers carry well-documented links to smoking, diet, or specific chemical exposures. Ewing sarcoma does not currently have an equivalent list.
Current Evidence and Research Gaps
No specific environmental exposure — radiation, industrial chemicals, or infectious agents — has been established as a cause of Ewing sarcoma, and diet, exercise, and smoking have not been shown to raise or lower risk either. This fits a disease driven primarily by a spontaneous genetic event rather than by cumulative outside exposure.
Because Ewing sarcoma is rare and its genetic signature so dominant, isolating a subtle environmental contributor is difficult, and researchers haven’t ruled out that unknown factors could play some role in triggering the underlying translocation. Until that evidence exists, prevention strategies built around avoiding specific exposures aren’t available for this cancer.
Ongoing Research into Ewing Sarcoma Causes
Understanding exactly how the EWSR1-FLI1 fusion drives cancer, and why it doesn’t cause disease in everyone who might carry a predisposing variant, remains an active area of study.
Genomic Sequencing and Biomarker Discovery
Sequencing studies of Ewing sarcoma tumors have identified secondary genetic changes beyond the founding fusion gene, including alterations in the STAG2 and CDKN2A genes, each found in roughly one in five to one in eight tumors, along with less frequent changes in TP53 and a handful of other genes. These findings are helping researchers build a fuller genomic picture of the disease, which overall has fewer additional mutations to target than many adult cancers.
Blood-based testing is part of this research picture too: whether tumor cells or tumor DNA can be detected circulating in the blood is one of the factors considered when evaluating a person’s outlook, and refining these tests for earlier detection or monitoring remains an area of active investigation.
Frequently Asked Questions
What is the primary genetic cause of Ewing Sarcoma?
Ewing sarcoma results from a chromosomal translocation that joins the EWSR1 gene to a partner gene — most often FLI1 — to form the EWSR1-FLI1 fusion gene, which the NCI reports is present in 85% to 90% of cases. The resulting abnormal protein disrupts normal gene activity and drives the tumor’s growth. This is an acquired change in the tumor’s DNA, not an inherited one.
Are there strong environmental risk factors for Ewing Sarcoma?
No. Unlike many other cancers, no environmental exposure, diet, or lifestyle factor has been established as a cause of Ewing sarcoma. Research continues, but the disease’s rarity and its strong, consistent genetic signature make outside contributors difficult to pin down.
Who is most commonly affected by Ewing Sarcoma?
Ewing sarcoma mainly affects children, teenagers, and young adults, and in the United States it is diagnosed roughly nine times more often in White individuals than in Black individuals, with an intermediate rate among Asian individuals. Most people who develop it have no family history of the disease.
Sources
